Iterum Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsIterum Therapeutics

Iterum Therapeutics(ITRM)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

type 2 diabetes mellitus

,

,

diabetes mellitus

,

lecithin cholesterol acyltransferase deficiency

,

,

influenza in birds

,

influenza a virus

,

hematopoietic stem cell transplantation

,

hemorrhagic cystitis

,

aids-related opportunistic infections

,

,

chondrocalcinosis

,

,

pharmacokinetics

,

breast neoplasms

,

acquired immunodeficiency syndrome

,

cytomegalovirus infections

,

,

bacterial infections

,

prehypertension

,

,

systolic heart failure

,

systolic murmurs

,

wounds and injuries

,

traumatic brain injuries

,

,

substance withdrawal syndrome

,

substance-related disorders

,

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

diabetes insipidus

,

nephrogenic diabetes insipidus

,

alcohol drinking

,

,

partial epilepsies

,

urinary tract infections

,

,

,

renal insufficiency

,

intraabdominal infections

,

,

,

,

communicable diseases

,

,

,

,

spinal cord injuries

,

male infertility

,

,

rna virus infections

,

,

vector borne diseases

,

,

flavivirus infections

,

viral hemorrhagic fevers

,

arbovirus infections

,

mosquito-borne diseases

,

,

cytomegalovirus retinitis

,

drug interactions

,

,

human influenza

,

fontan procedure

,

,

aids-related complex

,

central nervous system diseases

,

progressive multifocal leukoencephalopathy

,

,

kidney diseases

,

,

,

peritonsillar abscess

,

,

,

renal elimination

Sulopenem etzadroxil

,

pharmacokinetics

,

urinary tract infections

,

,

intraabdominal infections

,

communicable diseases

,

renal insufficiency

,

,

bacterial pneumonia

healthy volunteers/patients

,

,

kidney diseases

,

retinal diseases

,

,

non-small-cell lung carcinoma

,

,

large-cell lymphoma anaplastic

,

respiratory syncytial virus infections

,

pulmonary arterial hypertension

,

breast neoplasms

,

,

endometrial neoplasms

,

,

brain neoplasms

,

gram-negative bacterial infections

,

urinary tract infections

,

bacterial infections

,

wound infection

,

,

bacterial pneumonia

,

infectious skin diseases

,

soft tissue infections

,

,

healthcare-associated pneumonia

,

,

nontuberculous mycobacterium infections

,

chronic bronchitis

,

,

,

,

,

,

mycobacterium infections

,

community-acquired infections

,

,

gram-positive bacterial infections

,

,

,

communicable diseases

,

intraabdominal infections

,

mycobacterium avium-intracellulare infection

,

mycobacterium avium complex

,

,

,

,

,

ventilator-associated pneumonia

,

methicillin-resistant staphylococcus aureus

,

,

acute necrotizing pancreatitis

,

community-acquired pneumonia

,

,

,

,

abdominal abscess

,

Fluoroquinolone

healthy volunteers/patients

Hidroxicloroquina

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use